NASDAQ:VANI Vivani Medical (VANI) Stock Price, News & Analysis $1.38 +0.02 (+1.47%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.37 -0.01 (-0.72%) As of 08/8/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Vivani Medical Stock (NASDAQ:VANI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vivani Medical alerts:Sign Up Key Stats Today's Range$1.37▼$1.3950-Day Range$1.12▼$1.6252-Week Range$0.91▼$1.80Volume35,469 shsAverage Volume184,371 shsMarket Capitalization$81.75 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company Overview Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. Read More Vivani Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreVANI MarketRank™: Vivani Medical scored higher than 45% of companies evaluated by MarketBeat, and ranked 411th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingVivani Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageVivani Medical has only been the subject of 1 research reports in the past 90 days.Read more about Vivani Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Vivani Medical are expected to remain at ($0.41) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vivani Medical is -3.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vivani Medical is -3.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVivani Medical has a P/B Ratio of 4.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Vivani Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.11% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently increased by 2,726.27%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVivani Medical does not currently pay a dividend.Dividend GrowthVivani Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.11% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently increased by 2,726.27%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Vivani Medical this week, compared to 1 article on an average week.Search Interest2 people have searched for VANI on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,867.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders46.40% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 6.78% of the stock of Vivani Medical is held by institutions.Read more about Vivani Medical's insider trading history. Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address VANI Stock News Headlines3 Penny Stocks With Market Caps Over $30M To ConsiderJuly 16, 2025 | finance.yahoo.comVivani Medical Insiders Added US$5.29m Of Stock To Their HoldingsJune 30, 2025 | uk.finance.yahoo.comREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). | Weiss Ratings (Ad)Vivani Medical shareholders elect board and approve key proposals at annual meeting - Investing.comJune 27, 2025 | investing.comVivani Medical to Present at the 2025 BIO International ConventionJune 11, 2025 | finance.yahoo.comVivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani ShareholdersMay 29, 2025 | finance.yahoo.comVivani Medical Reports Q1 2025 Results and Strategic UpdatesMay 19, 2025 | tipranks.comVivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deSee More Headlines VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed this year? Vivani Medical's stock was trading at $1.16 at the start of the year. Since then, VANI shares have increased by 19.0% and is now trading at $1.38. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01. Who are Vivani Medical's major shareholders? Top institutional investors of Vivani Medical include Tanager Wealth Management LLP (1.72%). Insiders that own company stock include Gregg Williams, Joachim Eberhard Bolck, Aaron Mendelsohn, Donald Dwyer and Brigid Makes. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vivani Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Second Sight Medical Products (EYES), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB). Company Calendar Last Earnings5/13/2025Today8/10/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:VANI CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees20Year FoundedN/APrice Target and Rating Average Price Target for Vivani Medical$4.00 High Price Target$4.00 Low Price Target$4.00 Potential Upside/Downside+189.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.49 million Net MarginsN/A Pretax MarginN/A Return on Equity-133.07% Return on Assets-56.50% Debt Debt-to-Equity RatioN/A Current Ratio2.40 Quick Ratio2.40 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book4.60Miscellaneous Outstanding Shares59,240,000Free Float31,755,000Market Cap$81.75 million OptionableOptionable Beta2.99 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:VANI) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.